Concepedia

Rachel Herrup

RH

7

Publications

317

Citations

7

H-Index

2020

Active since

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

National Institutes of Health

Novartis Institutes for BioMedical Research

Spiez Laboratory

Rachel Herrup is an author at Center for Biologics Evaluation and Research specializing in medicine, covid-19, and immunology.

Top concepts

Publications per year

2020–2022

7

Publications

7

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Sabari Nath Neerukonda, Russell Vassell, Rachel Herrup et al. · PLoS ONE · 2021 · 139 citations · Full text

, , +11

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 56 citations · Full text

Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects

Sabrina Lusvarghi, Wei Wang, Rachel Herrup et al. · Journal of Virology · 2021 · 37 citations · Full text

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Sabari Nath Neerukonda, Russell Vassell, Rachel Herrup et al. · 2020 · 29 citations · Full text

, , +11

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

Eric D. Laing, Nusrat J Epsi, Stephanie A Richard et al. · 2021 · 24 citations · Full text

, , +21

Rows per page

1–5 of 7